“Supporting our systems: Addressing immunosenescence and improving adult immunisation in Europe”
The International Longevity Centre UK (ILCUK) report highlights how Europe's aging population faces increasing health challenges due to immunosenescence, which reduces vaccine effectiveness and increases vulnerability to disease.
Viral Infections and Risk of Cardiovascular Disease: Systematic Review and Meta‐Analysis
In self‐controlled case series studies, laboratory‐confirmed influenza infection was associated with an elevated risk of acute myocardial infarction and stroke during the first 1 month.
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
Immune checkpoint inhibitors (ICIs) extend survival in many patients with cancer but are ineffective in patients without pre-existing immunity.
Different vaccination debunking interventions: a randomized, controlled experiment estimating “backfiring” and positive effects
Misinformation about vaccines can hinder efforts to increase immunization rates.
Respiratory viral infections awaken metastatic breast cancer cells in lungs
Understanding the mechanisms that disrupt the quiescence of dormant disseminated cancer cells (DCCs) is crucial for addressing metastatic progression.
CLCI podcast episode: Life Course Immunisation and Global Health
This first episode positions life course immunisation within the global health landscape, framing it alongside the UN Sustainable Development Goals, the WHO European Immunisation Agenda 2030 and broader health equity aims.
Purification and characterization of recombinant neuraminidase as a potentially broadly protective influenza virus vaccine candidate
Influenza viruses pose a significant public health threat, causing seasonal epidemics and occasional pandemics with substantial morbidity and mortality worldwide.
Global immunisation monitoring in times of drastic cutbacks
Outbreaks of vaccine-preventable diseases are increasing at a time when funding for immunisation programmes is being cut.
